Corporate Banner
Satellite Banner
Genomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Cambio Provides Microzone PCR and DNA Reagents to Life Science Market

Published: Thursday, April 25, 2013
Last Updated: Thursday, April 25, 2013
Bookmark and Share
Cambio supplies Microzone’s MegaMix, microLYSIS® and MicroCLEAN products.

Cambio is able to supply its customers with a selection of reagents by Microzone. MegaMix, microLYSIS® and MicroCLEAN are each specifically designed as convenient and efficient solutions for PCR, DNA release and DNA clean-up respectively.

By incorporating these reagents into their procedures, life scientists can save time that would otherwise be spent creating their own mixes, as well as reducing risk of contamination.

Thanks to their standardized formulation, the Microzone reagents also dramatically increase the reproducibility of DNA amplification, giving researchers the upmost confidence in their methods, and therefore their results.

MegaMix is a PCR master mix containing all the fixed components needed for PCR amplification, including an enzyme cocktail consisting of two Taq polymerases, dNTPs, MgCl2, reaction buffers and enzyme stabilizers.

All these components are optimized to maximize yield with minimal non-specific background and the product is exceptionally easy to use - the MegaMix just has to be thawed, the recommended volume drawn and DNA and primers added.

MegaMix can survive multiple freeze/thaw cycles without deterioration of either product or function.

MegaMix is also available with dye to allow easy visualization, and double concentrated for added convenience.

In addition, Cambio also supplies Microzone’s MicroCLEAN and microLYSIS® products. MicroCLEAN is a rapid, one tube, one and half spin DNA reagent which cleans up any double stranded DNA from reaction buffers, enzymes, primers or dNTPs.

The versatile reagent has no limit on the size or volume of the target DNA and requires no additional manipulation, such as phenol extractions or spin columns.

Finally, microLYSIS® and microLYSIS®-Plus are novel reagents designed for use as a pre-step to PCR. When combined with rapid heating and cooling of thermocyclers, the unique mycroLYSIS® formulation effectively lyses the cells and enables users to reach the PCR stage in less than 15 minutes.

For tougher cell samples, such as those found in plant and some animal tissues, microLYSIS®-Plus can still offer the same impressive results.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Poor Survival Rates in Leukemia Linked to Persistent Genetic Mutations
For patients with an often-deadly form of leukemia, new research suggests that lingering cancer-related mutations – detected after initial treatment with chemotherapy – are associated with an increased risk of relapse and poor survival.
Searching Big Data Faster
Theoretical analysis could expand applications of accelerated searching in biology, other fields.
Growing Hepatitis C in the Lab
Recent discovery allows study of naturally occurring forms of hepatitis C virus (HCV) in the lab.
Inciting an Immune Attack on Cancer Cells
A new minimally invasive vaccine that combines cancer cells and immune-enhancing factors could be used clinically to launch a destructive attack on tumors.
Reprogramming Cancer Cells
Researchers on Mayo Clinic’s Florida campus have discovered a way to potentially reprogram cancer cells back to normalcy.
Genetic Overlapping in Multiple Autoimmune Diseases May Suggest Common Therapies
CHOP genomics expert leads analysis of genetic architecture, with eye on repurposing existing drugs.
Surprising Mechanism Behind Antibiotic-Resistant Bacteria Uncovered
Now, scientists at TSRI have discovered that the important human pathogen Staphylococcus aureus, develops resistance to this drug by “switching on” a previously uncharacterized set of genes.
How DNA ‘Proofreader’ Proteins Pick and Edit Their Reading Material
Researchers from North Carolina State University and the University of North Carolina at Chapel Hill have discovered how two important proofreader proteins know where to look for errors during DNA replication and how they work together to signal the body’s repair mechanism.
Fat in the Family?
Study could lead to therapeutics that boost metabolism.
Tissue Bank Pays Dividends for Brain Cancer Research
Checking what’s in the bank – the Brisbane Breast Bank, that is – has paid dividends for UQ cancer researchers.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!